Gefton 250 mg (containing Gefitinib) is a targeted cancer medicine used to treat advanced non-small cell lung cancer (NSCLC) with specific EGFR gene mutations.
Saint Petersburg, Russia, 440012
Gefton 250 mg (containing Gefitinib) is a targeted cancer medicine used to treat advanced non-small cell lung cancer (NSCLC) with specific EGFR gene mutations.